Home › Diffuse Large B-Cell Lymphoma › Wisconsin › Milwaukee
Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Milwaukee, WI
16 pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Milwaukee (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Nagre-recruitObservasyonal na pag-aaral
- Children's Hospital of Wisconsin, Milwaukee
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Nagre-recruitPhase 2
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mi ang layo
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi ang layo
- at 3 pa
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Nagre-recruitPhase 2
- Medical College of Wisconsin ( Site 0103), Milwaukee
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Nagre-recruitPhase 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Nagre-recruitPhase 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of ARC-02 in B-cell NHL
Nagre-recruitPhase 1
- Froedtert & Medical College of Wisconsin, Milwaukee
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Nagre-recruitPhase 1/2
- Medical College of Wisconsin, Milwaukee
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
Nagre-recruitPhase 2
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Nagre-recruitPhase 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Nagre-recruitObservasyonal na pag-aaral
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
DALY II USA/ MB-CART2019.1 for DLBCL
Nagre-recruitPhase 2
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Nagre-recruitPhase 1
- Medical College of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Nagre-recruitPhase 1/2
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Nagre-recruitPhase 2
- Medical College of Wisconsin, Milwaukee
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi ang layo
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Nagre-recruitObservasyonal na pag-aaral
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Nagre-recruitPhase 2
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- at 4 pa
Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod
- New York City, NY21 pag-aaral
- Baldwin Park, CA19 pag-aaral
- Chicago, IL18 pag-aaral
- Houston, TX17 pag-aaral
- Los Angeles, CA17 pag-aaral
- Boston, MA16 pag-aaral
- Nashville, TN15 pag-aaral
- Portland, OR15 pag-aaral
- Philadelphia, PA15 pag-aaral
- Durham, NC14 pag-aaral
- Dallas, TX13 pag-aaral
- Seattle, WA12 pag-aaral
Iba pang pag-aaral sa Milwaukee
- Kanser sa Suso23 pag-aaral
- Non-Small Cell Lung Cancer22 pag-aaral
- Kanser (lahat ng uri)22 pag-aaral
- Kanser sa Baga21 pag-aaral
- Multiple Myeloma21 pag-aaral
- Kanser sa Prostate20 pag-aaral
- Follicular Lymphoma19 pag-aaral
- Kanser sa Pancreas18 pag-aaral
- Non-Hodgkin Lymphoma18 pag-aaral
- Kanser sa Ovary17 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Burkitt Lymphoma16 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.